Barbara McNeil - Edwards Lifesciences Independent Director

<div class='logoBackup' style='background:#CD0D74;color: white;font-size:4em;padding-top: 15px;;'>EW</div>
EW -- USA Stock  

Earning Report: January 30, 2020  

  Director
Dr. Barbara J. McNeil, M.D., Ph.D., is Independent Director of the company. Since 1990, she has served as the Ridley Watts Professor of Health Care Policy at Harvard Medical School. In addition, since 1988, Dr. McNeil has served as the chair of the Department of Health Care Policy at Harvard Medical School. Since 1983, she was a Professor of Radiology at both Harvard Medical School and Brigham and Women Hospital. Dr. McNeil served as a director of CV Therapeutics, Inc., from 1994 to 2008. She also served as a director of Flagship Global Health, Inc., from 2005 to 2008. Dr. McNeil is a member of the Institute of Medicine of the National Academy of Sciences and the American Academy of Arts and Sciences. She is a member and former chair of the Medicare Evidence Development and Advisory Committee and is a member of the Blue Cross Medical Advisory Panel
Age: 74  Director Since 2006  Ph.D    
949 250-2500  www.edwards.com
McNeil holds an M.D. from Harvard Medical School and a Ph.D. in Biological Chemistry from Harvard University.

Management Efficiency

The company has Return on Asset (ROA) of 0.12 % which means that for every $100 of asset it generated profit of $0.12. This is way below average. Likewise, it shows return on total equity (ROE) of 0.27 % which means that it produced $0.27 on every 100 dollars invested by current stockholders.
The company reports 668.3 M of total liabilities with total debt to equity ratio (D/E) of 19.0 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences has Current Ratio of 3.31 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Showing few of many executives

DIRECTOR Since

Fred ChoateESCALON MEDICAL CORP
2005
Thomas HagedornElectromed
1997
Gregg WilliamsSecond Sight Medical Products
2018
Brian LarkinDynatronics Corporation
2015
Scott WardDynatronics Corporation
2013
Robrecht MichielsEDAP TMS SA
2009
Stan EricksonElectromed
2014
John SaywardDigirad Corporation
2008
David JacoviniESCALON MEDICAL CORP
2018
Charles GillmanDigirad Corporation
2012
David HungEstablishment Labs Holdings
2016
William LinkSecond Sight Medical Products
David NewtonENCISION INC
1991
Matthew PfefferSecond Sight Medical Products
2015
Erin EnrightDynatronics Corporation
2018
David HoltzDynatronics Corporation
2015
James MillerSecond Sight Medical Products
2015
Lisa GershEstablishment Labs Holdings
2019
Aaron MendelsohnSecond Sight Medical Products
N/A
John DogumESCALON MEDICAL CORP
2018
Larry BeardallDynatronics Corporation
1992

Entity Summary

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 12800 people.Edwards Lifesciences Corporatio (EW) is traded on BATS Exchange in USA. It is located in One Edwards Way, Irvine, CA 92614, United States and employs 12,800 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Independent Director
Wesley Schack, Presiding Independent Director
Larry Wood, Corporate Vice President - Transcatheter Aortic Valve Replacement
Nicholas Valeriani, Independent Director
Leslie Heisz, Independent Director
Catherine Szyman, Corporate Vice President - Critical Care
Martha Marsh, Independent Director
Huimin Wang, Corporate Vice President - Japan, Asia and Pacific
JeanLuc Lemercier, Corporate Vice President - EMEA (Europe, Middle East and Africa)
Barbara McNeil, Independent Director
Steven Loranger, Independent Director
William Link, Independent Director
Scott Ullem, Chief Financial Officer, Corporate Vice President
Patrick Verguet, Corporate VP of EMEA, Canada and Latin America
Kieran Gallahue, Independent Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
David Erickson, Vice President - Investor Relations
Donald Bobo, Corporate Vice President - Strategy and Corporate Development
Michael Mussallem, Chairman of the Board, Chief Executive Officer

Stock Performance Indicators

Did you try this?

Run Cryptocurrency Correlation Now

   

Cryptocurrency Correlation

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges
All  Next Launch Module

Edwards Lifesciences Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Edwards Lifesciences and ECHO THERAPEUTICS INC. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Investing Opportunities. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.